Chronic obstructive pulmonary disease (COPD) Trials in Spartanburg, United States
Conditions / Chronic obstructive pulmonary disease (COPD) / Spartanburg, United States
Chronic obstructive pulmonary disease (COPD) is a medical condition with active clinical research programs worldwide.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00846586 | Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT01857323 | Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI) | COMPLETED | PHASE3 |
| NCT06878261 | A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007) | RECRUITING | PHASE3 |
| NCT00877383 | Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT01727141 | A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. | COMPLETED | PHASE3 |
| NCT01854658 | Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2) | COMPLETED | PHASE3 |
| NCT01970878 | Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3) | COMPLETED | PHASE3 |
| NCT07082738 | A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease | RECRUITING | PHASE2 |
| NCT01302587 | A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) | COMPLETED | — |
| NCT00821093 | Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |